Axonics ROE 2017-2023 | AXNX
Current and historical return on equity (ROE) values for Axonics (AXNX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Axonics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $-0.01B | $0.64B | -0.82% |
| 2023-09-30 | $-0.01B | $0.61B | -1.87% |
| 2023-06-30 | $-0.03B | $0.60B | -5.40% |
| 2023-03-31 | $-0.05B | $0.58B | -8.43% |
| 2022-12-31 | $-0.06B | $0.57B | -11.68% |
| 2022-09-30 | $-0.08B | $0.55B | -15.52% |
| 2022-06-30 | $-0.08B | $0.44B | -16.23% |
| 2022-03-31 | $-0.08B | $0.46B | -16.50% |
| 2021-12-31 | $-0.08B | $0.48B | -17.72% |
| 2021-09-30 | $-0.08B | $0.49B | -18.87% |
| 2021-06-30 | $-0.07B | $0.50B | -19.22% |
| 2021-03-31 | $-0.06B | $0.33B | -20.84% |
| 2020-12-31 | $-0.06B | $0.29B | -20.93% |
| 2020-09-30 | $-0.07B | $0.29B | -28.30% |
| 2020-06-30 | $-0.08B | $0.30B | -44.56% |
| 2020-03-31 | $-0.08B | $0.17B | -58.47% |
| 2019-12-31 | $-0.08B | $0.18B | -61.54% |
| 2019-09-30 | $-0.07B | $0.09B | -55.83% |
| 2019-06-30 | $-0.05B | $0.11B | -48.54% |
| 2019-03-31 | $-0.04B | $0.13B | -53.69% |
| 2018-12-31 | $-0.03B | $0.14B | -81.44% |
| 2018-06-30 | $-0.02B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.427B | $0.366B |
| Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.875B | 21.62 |
| Inspire Medical Systems (INSP) | United States | $7.378B | 0.00 |
| 10x Genomics (TXG) | United States | $3.475B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.470B | 0.00 |
| Enovis (ENOV) | United States | $3.084B | 23.43 |
| Azenta (AZTA) | United States | $2.854B | 232.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.772B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.659B | 0.00 |
| Privia Health (PRVA) | United States | $2.118B | 93.95 |
| Schrodinger (SDGR) | United States | $1.811B | 0.00 |
| Phreesia (PHR) | United States | $1.306B | 0.00 |
| Omnicell (OMCL) | United States | $1.206B | 29.52 |
| Definitive Healthcare (DH) | United States | $0.847B | 0.00 |
| Standard BioTools (LAB) | United States | $0.757B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.497B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.316B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| Augmedix (AUGX) | United States | $0.155B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.19 |
| Outset Medical (OM) | United States | $0.112B | 0.00 |
| 111 (YI) | China | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| Akili (AKLI) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |